Warner Bros. Discovery shareholders approve Paramount Skydance merger

Warner Bros. Discovery shareholders approved Paramount Skydance’s $110 billion acquisition, with the offer valuing WBD at about $77 billion, or $31 per share. The deal remains subject to DOJ antitrust review and potential legal challenge from California, while political opposition and industry pushback continue. Paramount also paid Netflix a $2.8 billion termination fee after winning the bidding war.

Analysis

The near-term winner is WBD equity, but the more interesting read-through is to the antitrust overhang embedded across legacy media. A shareholder-approved deal with a rich headline value tends to compress the equity discount to deal value first, while the legal process drags out the optionality over months; that means WBD can still trade like a spread asset even as the probability-weighted close rises. The market is likely underestimating how much the FCC/DOJ process becomes a referendum on broader media concentration and political influence rather than on simple consumer price effects.

NFLX is the cleaner loser on a strategic basis, even though it is not directly in the merger. If the combined company rationalizes content spend and theatrical windows more aggressively, Netflix loses one of the few remaining large buyers willing to overpay for scale and prestige content, which can modestly improve industry pricing power for the incumbents but worsen Netflix’s margin optics at the next renewal cycle. The $2.8B termination fee is immaterial to the long-term competitive picture; the more important second-order effect is that failed bidding war discipline may encourage Netflix to stay selective, reducing M&A-driven volatility in streaming valuations.

ORCL’s signal here is not fundamental exposure but political adjacency: the Ellison family linkage creates a small but real governance premium/discount dynamic depending on whether regulators frame the transaction as ordinary consolidation or as politically favored media control. That makes the approval path asymmetric: a quick close is possible if the DOJ limits itself to classic remedies, but any California or congressional escalation could extend the timeline by 6-12 months and keep WBD’s stock pinned to deal risk. The contrarian view is that the market may be overpricing regulatory obstruction relative to the government’s current appetite for proving it can still greenlight a large, structurally complex transaction with behavioral commitments rather than blocking outright.

Key Decisions for Investors

• Long WBD vs short NFLX as a 3-6 month relative-value pair: WBD benefits from deal-value support and widening merger-arb demand, while NFLX faces a small negative read-through from reduced acquisition scarcity and tougher content economics. Target 8-12% spread capture; exit if DOJ litigation risk materially re-prices WBD below the implied close range.
• Buy WBD common on dips or through call spreads into regulatory headlines: favor 3-6 month 25/35 or 30/40 call spreads to express upside if approvals advance, with defined downside if the deal stalls. Risk/reward is attractive because most of the upside is event-driven, while downside is partially buffered by the transaction floor.
• Short a basket of legacy cable/linear exposure against WBD strength if deal momentum continues: use a basket of CMCSA, PARA, and DIS where available, because consolidation and content rationalization should pressure smaller distributors and slow-margin linear assets. Hold 1-2 quarters; cover if regulators impose remedies that preserve competition and limit synergies.
• Avoid chasing ORCL on the headline unless you explicitly want political-beta exposure: the linkage is more narrative than earnings-driven. If anything, use ORCL as a hedge only in a broader media-policy basket, not as a standalone trade.
• For merger-arb accounts, reduce outright spread exposure only if legal commentary shifts from delay to remedies that threaten break structure; otherwise keep a modest long WBD position. The key catalyst window is the next 30-90 days, when regulatory tone will matter more than shareholder votes.